PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study

Immune check-point inhibitors (ICIs) have changed our view on how to treat cancer. Despite their approval in treatment of many different cancers, efficacy of immune check-point inhibitors (ICI) in neuroendocrine neoplasia is limited and poorly understood. Established treatment options of neuroendocr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Özdirik, Burcin, Jann, Henning, Bischoff, Philip, Fehrenbach, Uli, Tacke, Frank, Roderburg, Christoph, Wiedenmann, Bertram
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2021
Témata:
5700
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793325/
https://ncbi.nlm.nih.gov/pubmed/33429744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023835
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky